Related Experiment Video
Updated: Sep 5, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney
Thaíza Passaglia Bernardes1, Gianna Mastroianni-Kirsztajn1
1Universidade Federal de São Paulo, Divisão de Nefrologia, São Paulo, SP, Brasil.
Introduction:
Membranoproliferative glomerulonephritis (MPGN) is a rare glomerular disease with a variable prognosis. A new classification based on the presence or absence of immunoglobulins and complement deposits in immunofluorescence microscopy (IF) of kidney biopsy has recently been proposed. The objectives of the study were to determine and compare the clinical, laboratory, and histopathological characteristics of those with primary or secondary MPGN, reclassify the primary ones based on IF findings, and evaluate kidney outcomes.
Methods:
This was an observational retrospective cohort study carried out in a single center (UNIFESP), based on the data collected from medical records of patients followed from 1996 to 2019.
Results:
Of 53 cases of MPGN, 36 (67.9%) were classified as primary and 17 (32.1%) as secondary MPGN. Most patients were hypertensive (84.9%) and had edema (88.7%) and anemia (84.9%); 33 (91.7%) patients classified as primary MPGN were reclassified as immune-complex-mediated and 3 (8.3%) as complement-mediated. The secondary MPGN group had hematuria more frequently (p <0.001) and a higher prevalence of deposits of IgG (p = 0.02) and C1q (p = 0.003). Regarding the outcome, 39% of the patients achieved partial or complete remission. Lower initial serum albumin and higher initial 24-hour proteinuria were factors associated with worst renal prognosis.
Conclusions:
According to the new histological classification, the vast majority of MPGN cases were classified as being mediated by immune complexes. There were few differences between primary and secondary MPGN in relation to their clinical and laboratory characteristics.
Insights
This study reclassified membranoproliferative glomerulonephritis (MPGN) using new histological criteria, finding most cases are immune-complex-mediated. Clinical and lab differences between primary and secondary MPGN were minimal.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease with varied prognosis.
- A new classification for MPGN based on immunofluorescence microscopy (IF) findings has been proposed.
- Understanding MPGN subtypes and outcomes is crucial for patient management.
Purpose of the Study:
- To characterize primary and secondary MPGN clinically, laboratorially, and histopathologically.
- To reclassify primary MPGN cases based on IF findings (immune deposits vs. complement).
- To evaluate kidney outcomes and identify prognostic factors in MPGN.
Main Methods:
- Observational retrospective cohort study.
- Data collected from medical records of 53 MPGN patients (1996-2019).
- Reclassification of primary MPGN based on IF and analysis of clinical/histopathological features.
Main Results:
- 36 cases (67.9%) were primary MPGN, 17 (32.1%) secondary.
- Most primary MPGN cases were reclassified as immune-complex-mediated (91.7%).
- Secondary MPGN showed more hematuria, IgG, and C1q deposits; 39% achieved remission; low albumin and high proteinuria predicted worse outcomes.
Conclusions:
- The majority of MPGN cases are immune-complex-mediated under the new classification.
- Clinical and laboratory characteristics showed limited differences between primary and secondary MPGN.
- Initial serum albumin and proteinuria levels are key indicators for MPGN renal prognosis.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrons

